Get the app
US › Healthcare

Repro Med Systems Inc (KRMD)

US · Healthcare · Medical Instruments & Supplies

$3.22+0.63%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$12.0M
Revenue YoY
+18.2%
Net profit
$252,449
EPS
$0.01
EPS estimate
$-0.02
Net margin
2.1%

EPS came in at 0.01 against a street estimate of -0.02 — a beat of 150.0%.

Key statistics

Market cap
$145.1M
Forward P/E
78.7
P/B
8.06
Book value
$0.39
EPS (TTM)
$-0.04
52-week high
$6.61
52-week low
$3.12
50-day MA
$3.71
200-day MA
$4.49
Beta
0.42

Analyst view

Analysts rate Repro Med Systems Inc a strong buy (4 buy, 1 hold, 0 sell out of 5) with an average price target of $6.25.

Shareholding

Insiders
8.17%
Institutions
56.45%

Largest institutional holders

FundStake
First Light Asset Management, LLC7.34%
Topline Capital Management LLC7.31%
BlackRock Inc5.14%
Vanguard Capital Management, LLC3.65%
Geode Capital Management, LLC2.28%
Simcoe Capital LLC1.79%
Meros Investment Management, LP1.65%
State Street Corp1.41%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Repro Med Systems Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.